ClinicalTrials.gg
CompletedNCT03322774STRIDEUpdated Oct 1, 2024

Sleep To Reduce Incident Depression Effectively

An interventional study of digital Cognitive Behavioral Therapy for Insomnia and face-to-face Cognitive Behavioral Therapy for Insomnia in Insomnia, Primary, Major Depressive Disorder and Rumination, sponsored by Henry Ford Health System. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-01.

Sponsored by Henry Ford Health System · Not applicable, Interventional, and Prevention

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,237
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 17 studies in Sleep Initiation and Maintenance Disorders by Henry Ford Health System — 3 open to participants now, 3 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Henry Ford Health System.

Enrollment
2nd of 15
1,237 · median 80
Started
2018
with 2 others
No phase
11 of 17
2 open now
Registered
7th of 17
by date

Among the 17 studies in Sleep Initiation and Maintenance Disorders by Henry Ford Health System, this one is the 2nd largest by enrollment of the 15 interventional ones that give a count, is one of 3 that started in 2018, is one of 11 with no phase, and was the 7th registered.

Sleep Initiation and Maintenance Disorders

2,732 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 733 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

3 of the 17 studies in Sleep Initiation and Maintenance Disorders by Henry Ford Health System are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 392 Sleep Initiation and Maintenance Disorders studies recruiting now, 155 (40%) set no upper age limit and 207 (53%) stop at 75 or younger; 59 take children under 18; 110 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 17 studies in Sleep Initiation and Maintenance Disorders by Henry Ford Health System, or all of them as a file.
02

Study summary

This project will assess the effectiveness of a stepped-care model (i.e. digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) followed by face-to-face CBT-I) in improving severity of insomnia and sleep outcomes in an insomnia cohort. This project will also investigate the effectiveness of this stepped-care model in prevention of major depressive disorder, and will test rumination as a mediator of treatment response.

Read the detailed description

This project will assess the acute and long-term effectiveness of dCBT-I on Research Domain Criteria (RDoC) sleep parameters: Insomnia Severity Index (ISI), sleep onset latency, and wake after sleep onset in an insomnia cohort including those at elevated risk for depression (e.g. low SES, minority). This will be tested by administering internet-based dCBT-I to people with insomnia and adding face-to-face CBT-I in non-remitters, as well as comparing the RDoC sleep outcomes to an attention control group post-treatment and at 1- and 2-year follow-ups. This study will also determine the acute and long-term effectiveness of face-to-face CBT-I in non-responders to dCBT-I on RDoC sleep outcomes relative to a comparison group post-treatment and at 1- and 2-year follow-ups.

This study will also determine the effects of dCBT-I and CBT-I using a stepped-care model for prevention of major depressive disorder incidence and relapse across 2 years. Specifically, rate of depression of both dCBT-I and CBT-I will be compared to a control group.

This study will also evaluate changes in rumination as a modifiable behavior (post-treatment) that mediates the effect of insomnia treatment on depression risk.

03

Conditions studied

  • Insomnia, Primary
  • Major Depressive Disorder
  • Rumination

Keywords

  • Stepped Care
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Determination of Insomnia (ISI > 14)
  • And no depressive symptoms (Quick Inventory of Depressive Symptomatology \< 11)

Exclusion criteria

Exclusion Criteria:

  • Age \< 18
  • Current use of antidepressants for depression
  • Bipolar or Seizure disorders
  • Known sleep disorders other than insomnia (e.g. obstructive sleep apnea, narcolepsy, restless leg syndrome).
  • Current major depressive disorder at baseline.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Participant)
Enrollment
1,237 participants (actual)

Study arms

  • Sham comparator
    Attention Control

    This group receives sleep hygiene education, which serves as a credible control intervention to digital cognitive behavioral therapy for insomnia (dCBT-I). This intervention mimics the web-based patient contact inherent in dCBT-I but is inert with respect to sleep outcomes.

    Behavioral: Sleep Hygiene Education Control

  • Experimental
    Stepped Care Model

    This group receives digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) through the third party program, "Sleepio." Following initial treatment with dCBT-I, individuals who do not experience remission of their insomnia will begin treatment with face-to-face Cognitive Behavioral Therapy for Insomnia with a trained staff member in behavioral sleep medicine.

    Behavioral: digital Cognitive Behavioral Therapy for Insomnia · Behavioral: face-to-face Cognitive Behavioral Therapy for Insomnia

  • Sham comparator
    Stepped Care Model Control

    This group receives digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) through the third party program, "Sleepio." Following initial treatment with dCBT-I, individuals who do not experience remission of their insomnia will receive sleep hygiene education, serving as a credible control intervention for comparison to the Stepped Care Model.

    Behavioral: digital Cognitive Behavioral Therapy for Insomnia · Behavioral: Sleep Hygiene Education Control

  • Experimental
    digital CBT-I

    This group receives digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) through the third party program, "Sleepio." Treatment includes weekly sessions of CBT-I administered over the internet in hour-long video sessions. Daily sleep diaries are recorded online for individual tailoring of treatment.

    Behavioral: digital Cognitive Behavioral Therapy for Insomnia

Interventions

  • Behavioraldigital Cognitive Behavioral Therapy for Insomnia

    Cognitive Behavioral Therapy for Insomnia administered online through the "Sleepio" program. Treatment utilizes sleep restriction, stimulus control, and cognitive therapy. Treatment is administered through 6 weekly, hour-long online video sessions with an animated figure called "The Prof," which delivers the treatment.

    Also known as: Sleepio, dCBT-I

  • Behavioralface-to-face Cognitive Behavioral Therapy for Insomnia

    Cognitive Behavioral Therapy for Insomnia administered by experienced staff trained in behavioral sleep medicine. Treatment utilizes sleep restriction, stimulus control, and cognitive therapy. Treatment is administered through 6 weekly, hour-long face-to-face sessions with an experienced staff member trained in behavioral sleep medicine.

    Also known as: CBT-I

  • BehavioralSleep Hygiene Education Control

    Participants are provided with information about good sleep hygiene through 6 weekly emails. Participants practice good sleep hygiene as part of their sleep routine. In Step 1, sleep hygiene control will be exclusively online. In Step 2, sleep hygiene control includes an in-person, face-to-face component.

06

What researchers measure

Primary outcomes

  1. Preventing major depressive disorder development with dCBT-I/CBT-I stepped care treatment for insomnia.

    Clinical interview by phone administered by trained personnel to determine DSM-5 major depressive disorder incidence and relapse. Major depressive disorder will specifically be determined by the structured clinical interview for DSM-5 (SCID-5) at 1- and 2-year follow-ups. Antidepressant history in the past 1 year is collected via online-administered surveys at 1- and 2-year follow-ups.

    Time frame: 1 and 2 years after initial randomization.

  2. Effectiveness of Stepped Care model of dCBT-I/CBT-I for insomnia remission.

    Insomnia remission rates based on the Insomnia Severity Index. Total score range 0-28 with higher scores meaning more insomnia. Remission = ISI \< 8.

    Time frame: Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.

  3. Mediation of Depression Prevention by Reducing Rumination (Nocturnal rumination)

    Rumination as measured by the Pre-Sleep Arousal Scale, Cognitive factor. Scores range from 8 to 40 with higher scores indicating more rumination. Treatment-related changes in rumination will be operationalized as changes from pre- to posttreatment.

    Time frame: Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.

Secondary outcomes

  1. Mediation of Depression Prevention by Reducing Rumination (Depressive rumination)

    Rumination as determined by the Rumination Response Scale. Scores range from 22-88 with higher scores indicating higher depressive rumination. Treatment-related changes in rumination will be operationalized as changes from pre- to posttreatment.

    Time frame: Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.

  2. Mediation of Depression Prevention by Reducing Rumination (Worry)

    Rumination as determined by the Penn State Worry Questionnaire. Scores range from 16-80 with higher scores indicating greater worry. Treatment-related changes in rumination will be operationalized as changes from pre- to posttreatment.

    Time frame: Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.

  3. Mediation of Depression Prevention by Reducing Rumination (Transdiagnostic)

    Rumination as determined by the Perseverative Thinking Questionnaire. Scores range from 15-75 with higher scores indicating greater perseverative thinking. Treatment-related changes in rumination will be operationalized as changes from pre- to posttreatment.

    Time frame: Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.

  4. Reducing subclinical depressive symptoms with dCBT-I/CBT-I stepped care treatment for insomnia.

    Depressive symptoms as measured by the Quick Inventory of Depressive Sympatomatology, 16 item self report version. Reductions in depressive symptoms will be operationalized as (1) pre to posttreatment changes, (2) pretreatment to 1-year follow-up changes, and (3) pretreatment to 2-year follow-up changes.

    Time frame: Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.

  5. Socioeconomic status as a moderator of depression prevention after stepped care insomnia treatment.

    Low socioeconomic status will be defined as annual household income \< $20,000. Stepped care treatment will be less effective for preventing depression for patients in poverty as compared to patients above the the poverty line.

    Time frame: Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.

  6. Racial minority identification as a moderator of depression prevention after stepped care insomnia treatment.

    Race will be self reported by patients. Stepped care treatment will be less effective for preventing depression for patients who self-identify as racial minorities (e.g., non-Hispanic black) relative to non-Hispanic white patients.

    Time frame: Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.

  7. Stepped care insomnia treatment of dCBT-I and CBT-I will significantly improve sleep parameters.

    Sleep parameters as captured by self-reported sleep onset latency, wake after sleep onset, and sleep efficiency.

    Time frame: Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.

07

Study locations

1 site
  • Henry Ford Medical Center - Columbus
    Novi, Michigan 48377, United States
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2018 to primary completion in Apr 2023, 61 months.

Of 1,216 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's 61 months is above that.

Counting every sponsor, half of 1,294 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 16, 2017
First posted
Oct 26, 2017
StartActual
Mar 9, 2018
Primary completionActual
Apr 30, 2023
CompletionActual
Jun 27, 2024
Last update
Oct 1, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03322774
Collaborators
Big Health Inc., University of Michigan
Responsible party
Christopher Drake (Principal Investigator, Henry Ford Health System) — Principal investigator
First posted
Oct 26, 2017
Start date
Mar 9, 2018
Primary completion
Apr 30, 2023
Completion
Jun 27, 2024
Last update
Oct 1, 2024

Study contacts

Christopher L Drake, PhD
principal investigator · Henry Ford Health System

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion